AI
AXA IM Alts
AXA IM Alts is a Series A to growth stage investment firm. It has made 8 investments. They made 1 investments in the last 12 months. Their most common stage is series-a (67% of deals). Average disclosed round size is $26.9M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
FC
Fiona Choi Kurz
Managing Director
RL
Rémi Lambert
Chief Investment Officer
AM
Antoine Mesnage
Head of Australia
JC
James Cox
Head of Funds Management (Australia)
MM
Maxime Margery
Portfolio Manager, Listed Real Estate
VH
Victoria Hall
Head of Funds, Infrastructure
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CChloris | Series A | $8.5M | Jul 2025 |
| LLimmaTech Biologics AG | Series A | $37M | Oct 2023 |
| LLimmaTech Biologics | Series A | $37M | Oct 2023 |
| LLimmaTech Biologics AG | Series A | $37M | Jan 2023 |
| EEyenuk | Series A | $26M | Oct 2022 |
| BBuen Manejo del Campo S.A. de CV | Series B | $15.6M | — |
| NNovoCuff | Series A | $26M | — |
| CCleanFiber INC | Series B | $28M | — |
| TThe Shared Wood Company | Growth | — | — |
Top Co-Investors
BNPP AM Alts4 shared
British International Investment2 shared
Tenmile2 shared
Factor[e]1 shared
AlphaMundi Group Ltd1 shared
FMO1 shared
KawiSafi Ventures1 shared
Novo Holdings1 shared
Novo Holdings A/S1 shared
Counteract1 shared
Orbia Ventures1 shared
Future Energy Ventures1 shared
Laerdal Million Lives Fund1 shared
RH Capital1 shared
Avestria Ventures1 shared
Kendall Capital Partners1 shared
Spring Lane Capital1 shared
Last updated: 8 September 2026